Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for Metastatic Breast Cancer
26 locations incl. Cerritos
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06324357·Phase 1, Phase 2·Recruiting·Listed Mar 2024